Skip To Main Content
Val Kennedy on Muck Rack

Val Kennedy

Verified
(She/Her)
Boston
As seen in: Seeking Alpha, Business Insider, Business Insider Singapore, MarketWatch, Flipboard, The Philadelphia Inquirer, MediaPost, NewsBreak, Mass Device, Endpoints News, BioCentury and
Covers:  IPOs, SPACs, emerging tech, biotech, medtech, cleantech, greentech.
Business editor based in Boston following biotech, medtech, greentech and other cool stuff.

Get in touch with Val

Contact Val, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Val Kennedy’s Biography

Read Full Bio →

A business and healthcare writer based in Boston, Val has written for many of the world's top news organizations, including MarketWatch, The Wall Street Journal, Dow Jones Newswires and Reuters. She currently serves as IPO Editor for Seeking Alpha, a leading investor news site.

Val Kennedy’s Journalist Portfolio

See all →
3 surprising traits of how COVID-19 affects patients, according to experts

3 surprising traits of how COVID-19 affects patients, according to experts

COVID-19 is a cunning disease that has taken many medical experts by surprise. The COVID-19 virus acts differ…

View article →
Medtech gets serious about cybersecurity

Medtech gets serious about cybersecurity

The medtech industry is getting serious about cybersecurity. At a recent seminar held by the Mass. Medical De…

View article →
Nothing bugs Cubist CEO Michael Bonney

Nothing bugs Cubist CEO Michael Bonney

BOSTON (MarketWatch) - By anyone's standard, Michael Bonney's first few days at Cubist Pharmaceuticals Inc. d…

View article →
Internet drug scams can make you sick

Internet drug scams can make you sick

BOSTON (MarketWatch) - Thinking of taking advantage of that super deal you just go emailed by an online pharm…

View article →
Getting the skinny on the latest diet pills

Getting the skinny on the latest diet pills

BOSTON (MarketWatch) -- Wall Street is betting that three new experimental diet drugs could be huge commercia…

View article →
Avian flu FAQ

Avian flu FAQ

BOSTON (MarketWatch) -- Here are answers to a few of the most frequently asked questions about avian flu and …

View article →

Articles

SA Asks: Is Intel overvalued, or does it still have upside?

|
By Val Kennedy Verified
| Seeking Alpha
Jul 27, 2026, 1:24 PM ET, By: , SA News Editor Is Intel's stock overvalued, or does it still have upside? Seeking Alpha analysts Rick Orford, Kevin Anthony D. Arroyo, and Kenio Fontes weigh in. Rick Orford: I wouldn't call Intel (INTC) overvalued so much as fully priced in To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Open in Who Shared Issue with article?

SA Asks: How will Trump's new tariffs impact the EU trade deal?

|
By Val Kennedy Verified
| Seeking Alpha
Jul 26, 2026, 5:46 PM ET, , , , , , , By: , SA News Editor This week, President Trump announced that the U.S. will impose tariffs of between 10% and 12.5% on goods imported from the vast majority of its trading partners. We asked Seeking Alpha analysts Jack Bowman, Eugenio Catone, and Luca To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Open in Who Shared Issue with article?

SA Asks: Does Netflix need to make an acquisition?

|
By Val Kennedy Verified
| Seeking Alpha
Jul 26, 2026, 1:46 PM ET, , , By: , SA News Editor Does Netflix (NFLX) need to make an acquisition? Seeking Alpha analysts Oliver Rodzianko, Steven Mallas, and Elina Selianska weigh in. Oliver Rodzianko: In my opinion, Netflix (NFLX) is probably best off if it reacquires its own stock. Management has long To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding.
Open in Who Shared Issue with article?
See all 5,394 articles